We are live on
!
Find out more
Squarepoint Portfolio holdings
AUM
$85.1B
1-Year Est. Return
20.93%
This Fund
S&P 500
This Quarter
Est. Return
+7.16%
1 Year Est. Return
+20.93%
3 Year Est. Return
+51.38%
5 Year Est. Return
+34.63%
10 Year Est. Return
+146.23%
AUM
$7.42B
AUM Growth
+$1.24B
(+20%)
Cap. Flow
+$985M
Cap. Flow
% of AUM
13.27%
Top 10 Holdings %
Top 10 Hldgs %
10.68%
Holding
3,037
New
854
Increased
791
Reduced
777
Closed
600
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$49.3M |
| 2 |
Intuit
INTU
|
+$48.7M |
| 3 |
Costco
COST
|
+$47.9M |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$47.4M |
| 5 |
Vanguard Real Estate ETF
VNQ
|
+$45.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$41M |
| 2 |
Dollar General
DG
|
+$39M |
| 3 |
Biogen
BIIB
|
+$36.8M |
| 4 |
iShares US Real Estate ETF
IYR
|
+$29.8M |
| 5 |
Waste Management
WM
|
+$29.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.19% |
| 2 | Consumer Discretionary | 16.12% |
| 3 | Healthcare | 11.21% |
| 4 | Financials | 10.17% |
| 5 | Industrials | 9.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1326
Lifecore Biomedical
LFCR
$162M
| $578K | 0.01% |
+59,445
| New | +$566K |
|
|
AUD
1327
DELISTED
Audacy, Inc.
AUD
| $577K | 0.01% |
358,432
+276,802
| +339% | +$414K |
|
1328
Bloom Energy
BE
$52.6B
| $576K | 0.01% |
+32,066
| New | +$479K |
|
|
CMBM
1329
DELISTED
Cambium Networks
CMBM
| $576K | 0.01% |
+34,130
| New | +$448K |
|
1330
Kiniksa Pharmaceuticals
KNSA
$4.83B
| $576K | 0.01% |
37,591
+14,559
| +63% | +$273K |
|
1331
Mattel
MAT
$4.17B
| $576K | 0.01% |
49,269
-266,037
| -84% | -$2.96M |
|
|
VRTU
1332
DELISTED
Virtusa Corporation
VRTU
| $576K | 0.01% |
11,723
-47,395
| -80% | -$1.88M |
|
|
JBTM
1333
JBT Marel
JBTM
$7.14B
| $574K | 0.01% |
6,251
-2,145
| -26% | -$205K |
|
1334
Douglas Emmett
DEI
$2.06B
| $573K | 0.01% |
22,819
-12,371
| -35% | -$349K |
|
1335
Weis Markets
WMK
$1.82B
| $571K | 0.01% |
+11,906
| New | +$586K |
|
|
GOLD
1336
Gold.com Inc
GOLD
$1.14B
| $570K | 0.01% |
+33,806
| New | +$427K |
|
1337
Cohen & Steers
CNS
$4.18B
| $570K | 0.01% |
10,222
+7,212
| +240% | +$445K |
|
|
AGEN
1338
Agenus
AGEN
$249M
| $569K | 0.01% |
7,251
+5,464
| +306% | +$425K |
|
|
BLD
1339
DELISTED
TopBuild
BLD
| $569K | 0.01% |
3,334
-27,274
| -89% | -$3.92M |
|
1340
Angi Inc
ANGI
$224M
| $568K | 0.01% |
+5,117
| New | +$705K |
|
1341
eHealth
EHTH
$42.5M
| $568K | 0.01% |
7,187
-3,349
| -32% | -$271K |
|
1342
iShares Russell 2000 Growth ETF
IWO
$14.5B
| $568K | 0.01% |
2,565
-8,264
| -76% | -$1.81M |
|
1343
HEICO Corp
HEI
$48.9B
| $566K | 0.01% |
5,405
-18,819
| -78% | -$1.94M |
|
1344
Loews
L
$24.3B
| $566K | 0.01% |
16,294
-36,989
| -69% | -$1.33M |
|
1345
Varex Imaging
VREX
$460M
| $566K | 0.01% |
+44,470
| New | +$608K |
|
|
EGRX
1346
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $566K | 0.01% |
13,334
+8,077
| +154% | +$353K |
|
1347
Allstate
ALL
$66.9B
| $565K | 0.01% |
5,998
-64,477
| -91% | -$6.02M |
|
|
PCH
1348
DELISTED
PotlatchDeltic
PCH
| $565K | 0.01% |
13,410
-6,076
| -31% | -$260K |
|
1349
Universal Technical Institute
UTI
$2.08B
| $565K | 0.01% |
111,208
+98,429
| +770% | +$692K |
|
1350
iHeartMedia
IHRT
$535M
| $564K | 0.01% |
69,450
+53,145
| +326% | +$452K |
|
Similar funds
Squarepoint's Q3 2020 Portfolio in Review
As of Q3 2020, Squarepoint held 3,037 positions worth $7.42B, up 20% from $6.18B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Squarepoint deployed $985M of net new capital in Q3 2020, opening 854 new positions and adding to 791 existing holdings. Its largest new stake was Salesforce: 186,017 shares worth $46.8M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Pfizer, an estimated $41M trimmed.
- Squarepoint's largest Q3 2020 buy was Salesforce: 186,017 shares worth $46.8M.
- Squarepoint added most to Visa in Q3 2020, an estimated $49.3M increase.
- Squarepoint's biggest Q3 2020 reduction was Pfizer, cutting an estimated $41M.
- Squarepoint fully exited Biogen in Q3 2020, selling an estimated $36.8M.
- Squarepoint's ten largest holdings make up 11% of its $7.42B portfolio in Q3 2020.
- Squarepoint opened 854 new positions and closed 600 in Q3 2020.
- Squarepoint's portfolio value rose 20% quarter-over-quarter to $7.42B.
Based on Squarepoint's 13F filing for Q3 2020, filed 16 Nov 2020.